Latest News and Press Releases

Phase 1 study of INCA33890 and muzastotug expected to begin in 2026 in 3L MSS CRC patients with and without liver metastases Study will be sponsored and conducted by Incyte; Adagene to provide...

SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other...

Dose-Dependent Efficacy Results: As of the latest data cut, muzastotug achieved a 31% (8/26) confirmed overall response rate (ORR) in the combined 20 mg/kg dose cohorts, showing a clear improvement...

Enrollment completed in CHAPTER-3, a pivotal study of deucrictibant XR for prophylactic treatment of HAE attacks; topline data anticipated in 3Q2026Timeline for submission of NDA dossier of...

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Medulloblastoma Drug Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights, covering...

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme (GBM) Treatment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers comprehensive...

Lichen planopilaris (LPP) is a highly morbid inflammatory scalp disorder that causes generally irreversible scarring hair loss, often accompanied by profound pain, itch, and burning sensations; no...

Lichen planopilaris (LPP) is a highly morbid inflammatory scalp disorder that causes generally irreversible scarring hair loss, often accompanied by profound pain, itch, and burning sensations; no...

Shanghai Hi-Dolphin’s COFE+ robot barista now serves 65+ countries: 2.35㎡, 10+ year lifespan, AI craft, 90% lower costs. The Light Store Era has arrived.

MetaTrim BHB keto ketone salt formula overview: BHB dosage research, proprietary blend analysis, pricing, and ingredient-level claim distinctions